Nesprins are multi-isomeric scaffolding proteins. Nesprin-1 and -2 are highly expressed in skeletal and cardiac muscle and together with SUN (Sad1p/UNC84)-domain containing proteins form the LInker of Nucleoskeleton and Cytoskeleton (LINC) complex at the nuclear envelope (NE) in association with lamin A/C and emerin. Mutations in nesprin-1/2 have been found in patients with autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD) as well as dilated cardiomyopathy (DCM). Several lines of evidence indicate that compromised LINC complex function is the critical step leading to muscle disease. Herein we review recent advances in our understanding of the functions of nesprin-1/2 in the LINC complex and mechanistic insights into how mutations in nesprin-1/2 lead to nesprin-related muscle diseases, in particular DCM and EDMD.
Introduction
Nesprins (nuclear envelope spectrin repeat proteins) are a family of multi-isomeric scaffolding proteins [1] . To date, six Klarsicht/ANC-1/Syne Homology (KASH) domain containing proteins: nesprins-1, -2, -3, -4, KASH5 and Lymphoid-restricted membrane protein (LRMP) have been identified, which are encoded by synaptic nuclear envelope (SYNE)-1, -2, -3, -4, KASH5 and LRMP genes [1-5]. Nesprin-1/2 localise at the nuclear envelope (NE) and interact with Sad1p/UNC84 (SUN) domain containing proteins, to form the linker of nucleoskeleton and cytoskeleton (LINC) complex in association with lamin A/C and emerin, thus providing a stable physical connection between the nucleus and the cytoskeleton. This complex participates in many cellular activities including maintaining nuclear morphology, regulating nuclear positioning and mechanical cell signalling as well as gene regulation [6] [7] [8] [9] . Nesprin-1 and -2 are highly expressed 3 in heart and skeletal muscle [1] . A number of mutations in SYNE1 and SYNE2 genes encoding nesprin-1 and -2 have been identified that are associated with dilated cardiomyopathy (DCM) and autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD 4 and 5) [10] [11] [12] [13] [14] [15] . In this review, we summarise all known nesprin-1/2-related muscle diseases as well as mouse models with cardiac and muscular phenotypes and discuss recent advances in our understanding of how nesprin dysfunction within the LINC complex causes nucleocytoskeletal uncoupling and chromatin disorganisation that manifests as defects in nuclear morphology, myonuclear positioning and distribution, aberrant mechanotransduction and gene regulation, leading to pathogenesis of these muscle disorders.
Nesprins and LINC complex
Nesprins-1 and -2 were first identified in screens for novel vascular smooth muscle cell (VSMC) differentiation markers [16] . Full-length human nesprin-1 and nesprin-2 are the second and third largest known proteins with molecular masses of ~1000kDa and ~800kDa respectively [1] . The typical structure of giant nesprin-1 and -2 consists of three major domains: A C-terminal KASH domain that is targeted to the NE, an N-terminal paired Calponin Homology (CH) domain that binds to the actin cytoskeleton, and a central rod domain containing multiple spectrin repeats (SRs) that link the CH and KASH domains and mediate protein-protein interactions [17] . Of note, there is a highly conserved adaptive domain (AD) at the C-terminus of nesprin-1 and -2, which acts to structurally stabilise the SRs in nesprin molecules [18, 19] . Extensive alternative transcription and splicing of SYNE1 and SYNE2 generate multiple nesprin-1 and -2 isoforms that vary greatly in size and those nesprin-1/2 isoforms exhibit multiple subcellular localisations [20] ( Figure 1A ). The giant isoforms localise at the outer nuclear membrane (ONM) and interact with SUN1/2 at the perinuclear space, forming the LINC complex that connects the nucleus to the actin 4 cytoskeleton [21] [22] [23] [24] . Smaller isoforms localise at the inner nuclear membrane (INM) and interact with emerin, SUN1/2 and lamin A/C via their SRs [25] . Lamin A/C can bind to DNA and core histones, while emerin can interact with lamin A/C and DNA-associated proteins such as barrier to auto-integration factor (BAF), which are important for maintaining chromatin architecture, regulating cell signalling and gene expression [26] [27] [28] . Recently, studies have shown nesprin-2 and the small nesprin-1 isoform, nesprin-1α, also localise at the ONM where they interact with the microtubule motor proteins dynein/dynactin, kinesin light chain-1/2 (KLC-1/2) and the centrosomal protein Akap450, a component of the microtubule-organising centre (MTOC) [12, [29] [30] [31] [32] .
Nesprin-1/2 are ubiquitously expressed, and are highly abundant in skeletal and cardiac muscle, in particular, smaller isoforms nesprin-1α2 and nesprin-2α1 [1, 33] . SYNE1 and SYNE2 genes share 64% homology [1]. Nesprin-1 is more conserved than nesprin-2 as the latter is relatively divergent in length and the first half of its amino acid sequence. However, both giant nesprin-1 and -2 are highly conserved in their CH domains and C-terminal region of the SR block, especially SRs69-71 of nesprin-1 and SRs51-53 of nesprin-2, as well as the adjacent unstructured AD domain, corresponding to small skeletal muscle and cardiac specific isoforms: nesprin-1α2, nesprin-2α1 and nesprin-2ε2 [18, 34] , suggesting they may play similar roles in muscle cell functions. The remaining portions of giant nesprin-1 and -2 rod domains may be more structural and have different roles in other tissues. Nesprin-3 is also ubiquitously expressed, and mainly interacts with plectin, the intermediate filaments cytolinker [2, 35] . Nesprin-4 is predominately expressed in epithelial cells [3, 36] . LRMP is expressed in a subset of taste receptor cells in mammals [37] and enriched in zebrafish zygotes [38] , whereas KASH5 is limited to meiotic cells [5, 39] . Both nesprin-4 and KASH5 can interact with microtubule motor proteins kinesin-1 or dynein/dynactin [3, 5] . In addition to forming the microtubule LINC complex, LRMP also binds calcium channel IP3 receptors to regulate taste signal transduction [37, 38] . Thus nesprins form a variety of LINCs that strengthen the connection between the nucleus and filamentous cytoskeletal networks.
Roles of nesprin-1/2 in muscle cell differentiation
The LINC complex has been revealed to play a major role in maintaining the position of the nucleus and its movements during cell migration and differentiation [40, 41] . A dynamic change of small and giant nesprin-1/2 isoforms has been shown to be involved in muscle differentiation although current knowledge in cardiac muscle cell differentiation is limited due to technical issues.
In human myoblasts, the expression of giant nesprin-1 is present and nesprin-1α2 is relatively low.
During myogenesis, nesprin-1α2 is upregulated and accompanied by a two-fold increase in nesprin-1 giant [12, 42] . Knockdown of nesprin-1 prevents mouse embryonic stem cells from differentiating into cardiomyocytes (CMs) [43] . In vitro, differentiation models have shown nesprin-2 isoforms re-localise from the NE of C2C12 myoblasts to the sarcomere of myotubes [25] . In vivo, during the transition from immature to mature muscle fibres, nesprin-2 giant partly replaces nesprin-1 giant at the NE and the short isoform, nesprin-1α2, becomes dominant [44] .
During myoblast differentiation, the expression levels of myogenic regulatory factors (MRFs) including myoblast determination protein (MyoD), myogenin and myosin heavy chain (MHC); microtubule (MT) motor protein KLC-1/2; as well as centrosomal proteins including Akap450, pericentriolar material 1 (PCM1) and pericentrin are increased in association with upregulated nesprin-1α in differentiated myotubes [12, 30, 45] . Proper nuclear positioning and movement is critical in muscle cell differentiation and development, and is driven by cytoskeletal 6 networks of MTs, actin and/or intermediate filaments, and involve a connection between the cytoskeleton and the NE, mediated by the LINC complex [29, 46] . Both nesprin-1 and -2 interact with KLC-1/2 through a highly conserved 'LEWD' motif at the AD region near the C-terminus of nesprin-1/2 and this interaction drives nuclear distribution during skeletal muscle cell differentiation [12, 29] . Furthermore, nesprin-1α has been shown to serve as a key factor to facilitate switching the MTOC from the centrosome in myoblasts to the cytoplasmic surface of the NE in myotubes by recruiting Akap450 to the NE to allow efficient microtubule nucleation and subsequent nuclear positioning, which is a critical step for nuclear spreading during muscle cell differentiation [30, 47] . These data suggest the combined actions of nesprin-1α-mediated KLC-1/2 recruitment and microtubule nucleation at the nucleus via Akap450 is essential for proper nuclear positioning in myotubes.
Nesprin-1/2 mutations and muscle disease
A wide range of cardiac and skeletal myopathies have been linked to mutations in LINC complex proteins [48] . DCM is characterised by dilatation and impaired contraction of the left or both ventricles, and is an important cause of heart failure and sudden cardiac death, particularly in the young [49] . EDMD manifests with skeletal muscle wasting with a distinctive humeroperoneal distribution early in the course of the disease and later extends to the proximal limb girdle musculature. Cardiac dysfunction is another feature of EDMD including heart conduction defects (CD) and DCM. Although CD and DCM always develop in a later stage of life, they are the main causes of mortality for these disorders [50] . Literature shows mutations in the LMNA gene (encoding protein lamin A/C), account for 5% of familial DCM [49, 51] and mutations in both LMNA and EMD genes together account for 40% of EDMD [52, 53] . How mutations in both lamin A/C and emerin, which are ubiquitously expressed proteins, can lead to muscle-specific diseases 7 has been a subject of debate for some time. Evidence suggests that their binding partners nesprin-1/2 and SUN1/2 are also involved in these diseases. Recently a total of 15 nesprin-1 and 6 nesprin-2 mutants as well as 7 SUN1/2 mutants were identified in EDMD and DCM patients [10] [11] [12] [13] [14] [15] [54] [55] [56] . Moreover, nesprin-1 mutants are identified in other muscular disorders such as congenital muscular dystrophy (CMD) and arthrogryposis multiplex congenita (AMC) [57] [58] [59] [60] (Figure 2 ). 14 out of 25 experimentally validated and characterised nesprin-1/2 mutants occur in the Cterminus of nesprin-1/2 giant, within the nesprin-1and region, which were identified in patients with muscle specific disorders, including several small family pedigrees as well as in sporadic EDMD patients with DCM [10, 12-15, 42, 56, 58, 60] . In these studies, nuclear morphology changes were commonly observed in mutant cells. Convoluted nuclear appearance as well as micronuclei, giant and fragmented nuclei were observed in patient fibroblasts or lymphoblasts [13, 14] . The perturbed localisation of LINC complex components and altered binding with nesprin-1/2 are another featured observation. Both lamin A/C and SUN2 were mislocalised from the NE in fibroblasts derived from EDMD patients or neonatal rat cardiomyocytes (NRCs) transfected with constructs encoding nesprin-1 mutations identified in DCM patients [12, 14] . The association between nesprin and lamin A/C, SUN and the microtubule motor protein KLC-1/2 were all disrupted by these nesprin mutations [12, 14] . Furthermore, during myoblast differentiation, reduced fusion capacity with decreased expression of myogenin and MHC was observed in C2C12 cells infected with nesprin-1 mutations identified in DCM patients [12] .
Centralised nuclei was another feature in EDMD patients accompanied by increased fibre size variability, fibrosis and apparent fat tissue in the skeletal muscle biopsy [15, 56] . In addition, expression levels of nesprin-1 were increased in fibroblasts derived from DCM patients and the localisation of nesprin-1 at the NE was totally absent in myoblasts derived from CMD patients [10, 30] . Disrupted LINC complex, altered nuclear morphology and perturbed myogenesis were also reported in EDMD/DCM disorders caused by lamin A/C or emerin mutations, suggesting that an intact LINC complex is critical for maintaining muscular physiological functions [61] [62] [63] [64] [65] .
In addition to muscular disorders, nesprin-1 mutations have been shown to cause the neurological disorder autosomal recessive cerebellar ataxia type 1 (ARCA1) [66] [67] [68] [69] . ARCA1 is characterised by progressive problems with cerebellar dysarthria, limb and gait ataxia and diffuse cerebellar atrophy [70] . It is intriguing that the nesprin-1/2 mutations result in such distinctly different diseases affecting either muscle or the central nervous system (CNS).
Comparing the mutations of SYNE1/2 that affect both muscle and CNS systems, it is apparent that the majority of nesprin-1 mutations associated with muscle diseases, especially those experimentally validated and characterised, are heterozygous missense mutations at the Cterminus of nesprin-1 giant, and are all within the muscle specific isoform nesprin-1α2. These mutants cause amino acid substitutions, resulting in changes in charge or hydrophilic/hydrophobic properties of conserved amino acids and are likely to affect the structure/flexibility of the functional regions of both nesprin-1 and -2 due to the high homology and conservation in their Cterminal regions [34] . In contrast, mutations affecting CNS development are homozygous and scatter along the whole SYNE1 gene. They are nonsense mutations and introduce a stop codon.
This premature stop codon results in many truncated nesprin-1 variants lacking either SRs and/or KASH domains or total loss of nesprin-1 due to nonsense-mediated decay of mutant mRNA [69, 71] . The varied positions of SYNE1/2 mutations and their related diseases indicate: 1) the KASH domain and CH domain containing isoforms have tissue specific scaffolding functions in muscle and CNS respectively due to the differential homology and conservation of their amino acid sequence and structure in these isoforms. Mutations near/in the KASH domain of nesprin-1 or -2 may affect the muscle functions in both nesprin-1 and -2 while mutations in CH domains/Nterminal and central part of nesprin-1 mainly cause defects in neural/brain isoforms of nesprin-1, which could partly explain why the mutations causing ARCA1 were only reported in SYNE1 rather than SYNE2. 2) In muscle disease, mutations in SYNE1/2 similar to LMNA or EMD, are mainly independent muscular disorder-causing genes [14] . In contrast, SUN1/2 are thought to be disease modifier genes in individuals with co-segregating mutations in other EDMD causing-genes such as LMNA, EMD, and LAP2α [54, 55] . 3) The different localisations of nesprin mutations may impair different functions of the LINC complex. Nesprin mutations in the SR regions at the Cterminus are more likely to induce nuclear morphology defects and disrupt associations with the nesprin binding proteins lamin A/C, emerin and SUN at the NE, promoting LINC complex instability. Changes in LINC complex stability perturb mechanotransduction in muscle cells especially when subject to mechanical strain [72] . Nesprin mutations in the AD region have more effects on the interaction with microtubule motor protein KLC-1/2, resulting in defects in nuclear migration and positioning, perturbing myogenesis and muscle maturation [12] .
Nesprin-1/2 mouse models with cardiac/skeletal muscle phenotypes
To further understand the roles of nesprins in the LINC complex and in nesprin-related muscle diseases, more than 10 nesprin mouse models have been generated. Two of these spontaneously developed cardiac phenotypes and nearly half showed skeletal muscular disorders. 
Nesprin-1/2 mouse models with cardiac phenotypes

Nesprin-1/2 mouse models with skeletal muscle phenotypes
Other nesprin mouse models such as nesprin-1 or 2 KASH overexpression, nesprin-1 or 2 KO, and nesprin-1α2 KO mice all exhibited the skeletal muscle defects [73, [75] [76] [77] [78] . One of the main features in these mice was abnormal nuclear positioning along skeletal myofibers. The variability of muscle fibre size was also increased [77] . Myonuclei clusters or arrays were observed in the longitudinal section [76] [77] [78] , whilst centralised myonuclei were present in the cross section of muscle fibres [73, 77] . The function of muscle fibres was also compromised in nesprin-1 mutant mice. Myonuclei were detached when the sarcolemma was peeled off from muscle fibres, and nuclear aspect ratio (length divided by width) showed less change with fibre strain in nesprin-1 KO mice when compared with wild type (WT), indicating defective nuclear anchorage and decreased strain transmission from perinuclear regions to the nuclei [77] . Moreover, absence or overexpression of the KASH domain resulted in the expulsion of synaptic nuclei from the neuromuscular junction (NMJ) to the peripheral region, causing longer motor nerve branches, which was important for proper motor neuron innervation and respiration [75, 76] . In addition to the muscular and cardiac phenotypes, the literature also reported misshapen nuclei in epithelial cells and defective cell migration in the retina caused by deletion of nesprin-2 CH domain or KASH2 respectively [32, 79] .
The data generated from these mouse models suggest the C-terminal region of giant nesprin-1/2 and nesprin-12 isoforms play an important role in muscle cell function, especially in nuclear positioning in developing skeletal muscle.
Pathogenic mechanism of nesprin-1/2 dysfunction
Nesprin-1/2 localise at the NE, forming the LINC complex with SUN1/2, lamin A/C and emerin. This complex is integrated for linking the nucleus to actin cytoskeleton. Currently there are two key hypotheses that have been proposed for the pathological mechanisms underlying these muscle diseases. The structural hypothesis (transcriptional independent): suggesting the LINC complex plays a role in nucleocytoskeletal coupling by regulating both force transmission and balance of the relations between the nuclear lamina, microtubules, kinesin-dynein motor counteraction, myosin and other biological processes. The gene regulation hypothesis (transcriptional regulation): suggesting structural changes in the LINC complex may uncouple chromatin from the NE and cytoskeleton and affect mechanotransduction/signalling which may eventually lead to genome reorganisation and transcriptional dysregulation. In muscle diseases, the two hypotheses are not mutually exclusive and the consequence of any defects can be summarised into the following detailed aspects: ( Figure 1B) .
Firstly, nesprin-1 mutations alter nuclear morphology [10, 12, 14, 74] , mis-localise its binding partners lamin A/C, emerin and SUN2 from the NE [12, 14, 74] and perturb their interactions [12, 14] . This causes disruption of the LINC complex and thereby compromises its functions as a physical linker and force transmission propagator. Meanwhile, mutated nesprin-1 also perturbs the interaction with the microtubule motor proteins KLC-1/2 and centrosomal protein Akap450 at the ONM [12, 29, 30] , leading to disassembly of the link between the nucleus and the microtubule.
Secondly, nesprin is the key element to ensure proper nuclear positioning and migration which was initially examined in lower organisms. In C. elegans, mutated ANC-1 (a nesprin orthologue) results in freely floating and grouped nuclei in the cytoplasm of hypodermal syncytium [80] . In Drosophila melanogaster, mutated MSP-300 (a nesprin orthologue) leads to mis-localised 13 nuclei in oocytes [81] . Similarly, in mammalian myoblasts, the nesprin-1 mutation (E7854X) abolishes the recruitment of Akap450 to the NE during muscle cell differentiation and another nesprin-1 mutation (R8272Q) near the 'LEWD' motif disrupts its binding with KLC-1/2 [12, 29] .
These nesprin-1 mutations affect microtubule-mediated nucleation and nuclear migration/positioning, leading to defects in myogenesis.
Thirdly, mutations in SYNE1/2 that disrupt muscle specific nesprin-1 and -2 isoforms, or mutations in other components (LMNA, EMD and SUN1/2) of the LINC complex that disrupt their binding with muscle specific nesprin-1 and -2 isoforms, lead to defects in nuclear morphology and nucleocytoskeletal coupling [10, 14, 54, 55, 82] . They are also likely to influence chromatin structural integrity as mis-localised emerin and lamin A/C could also alter binding with DNA, core histones and the chromatin-associated proteins BAF [26] [27] [28] 83] . Disruption of these interactions would affect cell signalling and gene regulation including: augmented cell signalling (hyperactivation of MAPK kinase) [12] , dysregulated gene expression (perturbed expression of MRFs in muscle cell differentiation in vitro and cardiac foetal genes and fibrotic genes in heart in vivo) [12, 74] and abnormal mechanotransduction (altered mechanosensitive genes in CMs derived from nesprin-1/2 DKO mouse) [74] . These aspects of compromised functions of the LINC complex further support the structural and gene regulation hypothesises, contributing to pathogenesis of EDMD and DCM.
Concluding remarks
Over past decades, nesprin associated muscular diseases have emerged and nesprin mouse models with skeletal and/or cardiac muscle phenotypes have been generated. Our knowledge of the roles of nesprin-1/2 in NE organisation and myogenesis have expanded dramatically, which has aided our understanding of how nesprin-1/2 mutants contribute to DCM and EDMD via the LINC complex associated structural disruption and gene dysregulation. However, we still lack a complete understanding of the diverse nesprin isoforms, the myriad of nesprin binding partners and their interactions/functions with the LINC complex in muscle cells. Additionally, increased evidence has implied that nesprin-1 and -2 also participate in formation of the NE-MTOC, Ca 2+ /Calmodulin mediated nuclear trafficking and mitochondria positioning [30, 84, 85] .
Interestingly, they are also present at the sarcomere in addition to their localisation at the NE [14, 25] . Thus, future studies focusing on these aspects of nesprin-1/2 functions and utilizing derived induced Pluripotent Stem Cells (iPSCs) and/or myoblasts derived from patients, as well as generating cardiac or muscle specific nesprin mutant knock-in mouse models will help to decipher the underlying mechanisms enabling the development of potential diagnostic and therapeutic targets for these muscular disorders. 
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